First Trust NYSE Arca Biotechnology Index Fund (FBT)

149.71
Delayed Data
As of 10:38am ET
 -1.06 / -0.70%
Today’s Change
111.23
Today|||52-Week Range
151.28
+20.18%
Year-to-Date

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

What Investors Need to Know about Biotech ETFs
Jul 12 / Zacks.com - Paid Partner Content
Biotech ETFs Surge on Biogen's Positive Drug Trial Result
Jul 09 / Zacks.com - Paid Partner Content
5 Safe and Sound ETF Strategies for 2H
Jul 09 / Zacks.com - Paid Partner Content
 

Performance

1 month+4.94% 3 years+6.39%
3 months+10.62% 5 years+18.46%
1 year+30.25% Since inception+18.36%
Data through 07/14/2018

Quote Details

Previous close$150.77
Open day’s range149.29 – 150.70
Net asset value (NAV)150.75 (07/13/2018)
Daily volume6,683
Average volume (3 months)63,076
Data as of 10:38am ET, 07/16/2018

Peer Comparisonvs. Health ETFs

 FBTCategory
Performance 5-yr return+18.46%+14.50%
Expense Gross exp ratio0.56%1.29%
Risk 5 year sharpe ratio0.850.94
Net assets$1.6B$3.1B
Average market cap$11.7B$28.5B
Average P/E27.225.2
Dividend / Share--0.32%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RARE Ultragenyx Pharmaceutical Inc4.58%
FGEN FibroGen Inc4.34%
SGEN Seattle Genetics Inc4.26%
NBIX Neurocrine Biosciences Inc3.99%
ICPT Intercept Pharmaceuticals Inc3.79%
ALXN Alexion Pharmaceuticals Inc3.68%
ILMN Illumina Inc3.67%
BMRN Biomarin Pharmaceutical Inc3.61%
BIIB Biogen3.58%
QGEN Qiagen NV3.55%